The Liquid Biopsy Market in 2023 is US$ 5.1 billion, and is expected to reach US$ 19.84 billion by 2031 at a CAGR of 18.52%.
FutureWise Research published a report that analyzes Liquid Biopsy Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Liquid Biopsy Market Size, Overview, Share and Forecast 2031.
1. Liquid Biopsy Market Size, Overview, Share and Forecast 2031
The Liquid Biopsy Market in 2023 is US$ 5.1 billion, and is expected to reach US$ 19.84 billion by
2031 at a CAGR of 18.52%.
The Surging Surge of the Liquid Biopsy Market in Health Technology
The healthcare sector is undergoing a profound transformation, driven by technologies that
promise to reshape patient care paradigms. One such technological marvel is the liquid biopsy—
a non-invasive procedure offering to diagnose, monitor, and guide treatment of diseases
through a simple blood draw. But what does the burgeoning liquid biopsy market mean for the
era of precision medicine and patient care? Join us as we dissect the dynamics of this innovative
market and contemplate the potential for a healthier future.
Understanding the Liquid Biopsy Phenomenon
The term 'liquid biopsy' is relatively new in clinical diagnostics, but it is leaving an indelible mark
on how we approach patient health management. Unlike traditional biopsies that often require
invasive procedures to obtain tissue samples, liquid biopsies analyze cell-free DNA, circulating
tumor cells, or other biomarkers released into the blood, providing a window into a patient’s
health with considerably less intrusion.
This groundbreaking approach has particular relevance in oncology, where it enables oncologists
to identify cancer at early stages, provide dynamic monitoring of the disease, and personalize
treatment regimes based on the genetic makeup of tumors. The implications of liquid biopsy,
however, extend well beyond oncology and into numerous areas of health, from prenatal
screening to organ transplants.
Market Growth and Projections
The liquid biopsy market is currently at an inflection point, gaining momentum as both
technology and adoption reach critical mass. Projections indicate a market poised for
exponential growth, with expectations that it could reach unprecedented heights in the next five
to ten years.
Factors driving this growth include the increasing incidence of cancer and other chronic diseases,
the demand for non-invasive sampling methods, advances in molecular diagnostics, and the push
for personalized medicine. Additionally, the liquid biopsy market stands to benefit from the
increasing awareness of early disease detection, minimally invasive procedures, and the
integration of next-generation sequencing (NGS) technologies.
2. At the forefront of this surge are companies innovating in the fields of diagnostic technology and
bioinformatics, from startups disrupting the status quo to established players pivoting into the
liquid biopsy space. The market dynamics are complex, with issues such as technology efficacy,
regulatory considerations, and reimbursement models playing pivotal roles in market
penetration and acceptance.
The Research Landscape of Liquid Biopsy
An essential element of the liquid biopsy narrative is its robust research ecosystem. Academic
institutions, research organizations, and industry players are continuously working to advance
the field, unveiling new biomarkers and refining the technology to enhance sensitivity and
specificity.
The research endeavors are casting a wide net, from large-scale clinical trials validating liquid
biopsy platforms to high-impact publications demonstrating the clinical utility of these tests.
Such efforts are crucial for not only expanding the potential applications of liquid biopsy but also
for garnering support from the medical community and regulatory bodies.
FutureWise Research published a report that analyzes Liquid Biopsy Market trends to predict the
market's growth. The report begins with a description of the business environment and explains
the commercial summary of the chain structure. Based on the market trends and driving factors
presented in the report, clients will be able to plan the roadmap for their products and services
taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst
numerous associated corporations including the analysis of market evaluation and options
associated with the worth chain. This Liquid Biopsy research report provides insights on market
overview, market segmentation, current and future pricing, growth analysis, competitive
landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Liquid Biopsy Market Sample
Liquid Biopsy Market Segmentation:
By Product
Assays Kits
Instruments
Services
3. By Circulating Biomarker
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
By Clinical Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics
By Application
Oncology
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Melanoma Cancer
Other Cancers
Non-Cancer Application
By End User
Reference Laboratories
Hospitals and Physician Laboratories
Academic and Research Centers
Other End Users
By Region
North America
Latin America
Europe
Asia Pacific
Rest of the World
Major players included in the Liquid Biopsy Market:
Biocept Inc.
Qiagen N.V.
Roche Diagnostics.
4. Bio-Rad Laboratories, Inc.
Myriad Genetics, Inc.
Menarini-Silicon Biosystems.
Trovagene Inc.
Guardant Health, Inc.
Mdxhealth SA.
Genomic Health Inc.
Please visit full report of the Liquid Biopsy market @ Visit Liquid Biopsy Market
Competitive Landscape:
Tier one players - market players with a significant share of the market
Tier two players
Players with rapid growth
New Entries
FutureWise Key Takeaways:
• Prospects for growth
• Analysis of SWOT
• Key trends
• Key Data-points affecting market growth
Objectives of the Study:
• To provide report with an in-depth analysis of the Liquid Biopsy Market By Type, By
Application and By Region
• To offer data-points and comprehensive data on factors affecting the market (Opportunities,
drivers, and industry-specific restraints)
• Analysis and forecasting of micro-markets, as well as the scope of the market.
• To predict the size and share, market forecast, in key regions — North America, Europe, Asia
Pacific, and rest of the world
• To record and evaluate competition -mergers and expansions, product launches, and
technological advancements within the market
Related Markets:
Automated Radiosynthesis Modules Market
Eye Drops and Lubricants Market
Human Growth Hormone (HGH) Market
Flexible Delivery Model:
5. • With our flexible delivery model, you will be able to suggest changes within the scope/table
of content based on your requirement.
• Customization services are included with the purchase of any license type of report.
• Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com